Status:
WITHDRAWN
Intron A for the Treatment of Hypertrophic Scar
Lead Sponsor:
University of Alberta
Conditions:
Burn
Hypertrophic Scar
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
This study assesses the intervention with antifibrotic agents, specifically interferon (IFN) to reduce the magnitude and duration of hypertrophic scar. Burn patients with hypertrophic scar are randoml...
Detailed Description
Burn patients being followed and treated in the Outpatient Burn Clinic with large areas of HTS are approached to participate in the study. Patients who agree to participate and who have signed an info...
Eligibility Criteria
Inclusion
- burns \> 5% tbsa
- informed consent
- no prior exposure to interferon or other cytokines
Exclusion
- history of cardiac or CNS disorder or disease
- autoimmune disease
- immunodeficiency
- abnormal renal or hepatic function
- pregnancy
- serious intercurrent illness
- active infection
- malnutrition
- active drug or alcohol abuse
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00686478
Last Update
January 30 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta
Edmonton, Alberta, Canada, T6G 2B7